DynoSense raises $9.4m for digital health device
US-based DynoSense has raised $9.4m in funds, with investors including WI Harper Group, JKOM Cloud Health Technology and Jinmao Capital. DynoSense's remote-monitoring device, called DynoSensor, measures electrocardiography, pulmonary plethysmography , blood pressure change, hydration level, sleep, core body temperature, and activity. After data is collected by the device it is uploaded to a cloud platform, where it can then be analysed and sent on to clinicians. The device is designed to be used in elderly care, chronic disease care, hospital discharge care and telemedicine.
Sunnyvale, California-based DynoSense, which has developed a mobile-enabled sensor that tracks a number of vital signs and other health biometrics, raised $9.4 million from WI Harper Group, JKOM Cloud Health Technology, Plug and Play Tech Center, Jinmao Capital, and Wilson, Sonsini, Goodrich and Rosati.

DynoSense's device, called DynoSensor, measures ECG, EKG, pulmonary plethysmography (PPM), blood pressure change, hydration level, sleep, core body temperature, and activity. The company claims the device can capture more than 33 critical health metrics in less than 60 seconds with a single user action. After data is collected, it's uploaded to a cloud platform, analyzed and can then be sent on to a care team. Users can access this data via mobile devices, set individualized alert levels for certain data values, and share the data with family members as well as caregivers.

The device is designed to be used in managed elderly care, chronic disease care, hospital discharge care, consumer health, and telemedicine.

“Our mission is to be at the forefront of the digital healthcare revolution, a market anticipated to reach more than $26 billion by 2020,” DynoSense CEO Saeed Azimi said in a statement. “With the Dyno, we are marking a new paradigm in how patients can be remotely monitored for physiological changes. We believe this will open up a whole new era of disease prevention that will enhance delivery of care, resulting in leapfrog improvements in efficiency, health outcomes and cost reduction.”

The company will use the funds to start working towards an FDA clearance and commercializing the DynoSensor.

In a video describing the device, Azimi explained that his device is similar to a tricorder, a future category of health sensing devices capable of diagnosing various ailments. This type of device gained popularity after Qualcomm launched a competition, called the Tricorder X Prize, which wraps up in 2016. A few months ago, two of the finalists in the Tricorder X Prize, Scanadu and Intelesens announced that they were merging their teams into one.